/Investor DB

Xeraya Capital — 2020 Investments

3 investments dated 2020 · listed companies and verified rows first · show all

Congenicacongenica.comNov 2020

Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB

Co-investorsCambridge Innovation CapitalFuture Planet CapitalQVenturesAmadeus Capital PartnersIDO InvestmentsLegal & General+3 more

Imagoimagobio.comin𝕏Nov 2020 · $80Macquired by Merck

A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.

BiotechHealthtech

Co-investorsFrazier Life SciencesHighlight CapitalMRL Ventures FundAmgen VenturesBlackRockBlackstone Life Sciences+5 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

GreenLight Pandemic Response

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.